{"id":510471,"title":"Submission 'Class' - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T07:57:12.381000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drug-health-product-review-approval/submissions-under-review/submission-class.html","snippet":"Submission 'Class' Health Canada announced in August 2018 that implementation of Phase III of the Submissions Under Review (SUR) List initiative will proceed. For eligible submissions (new drug submissions and eligible supplemental new drug submissions) accepted into review on or…","rawSnapshotUrl":"/api/snapshots/raw/510471","browseUrl":"https://replay.healtharchive.ca/job-6/20260216075712/https://www.canada.ca/en/health-canada/services/drug-health-product-review-approval/submissions-under-review/submission-class.html#ha_snapshot=510471","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}